EFTA Document EFTA01892983

To: Barrett. Paul S From: Jeffrey Epstein Sent Mon 8/20/2012 2:06:08 PM Subject Re: FW: **NEW ISSUE" JPMORGAN CHASE & CO PREFERRED STOCK ok On Mon, Aug 20, 2012 at 9:13 AM, Barrett, Paul S < wrote: Jeffrey We should do $2.5MM in this deal. Let me know Paul Paul Barrett, CFA Managing Director Global Investment Opportunities Group JPMorgan Private Bank 320 Park Avenue, 14th Floor New York, NY 10022 (W) (F) NMLS ID# 853441 Original Message From: US GIO Sent: Monday, August 20, 2012 8:47 AM Subject: **NEW ISSUE** JPMORGAN CHASE & CO PREFERRED STOCK ISSUER: JPMORGAN CHASE & CO. [Ticker: JPMJ EXPECTED RATINGS: Bal/BBB/BBB- SIZE: $500mm (20mm shares) TYPE: Depositary Shares Each Representing a 1/400th Interest in a Share of _% Non-Cumulative Perpetual Preferred Stock, Series O FORMAT: SEC Registered MATURITY: Perpetual OFFER PRICE: $25.00 per depositary share DIVIDENDS: When, as, and if declared, dividends will accrue and be payable quarterly in arrears, on the 1st of March, June, September and December beginning December 1st, 2012 OPTIONAL REDEMPTION: Subject to regulatory approval, (1) in whole or EFTA_R1_00314529 EFTA01892983 in part, from time to time, on any dividend payment date on or after , 2017 at Par plus any declared and unpaid dividends, or (2) in whole but not in part, at any time within 90 days after a capital treatment event, we may provide notice of our intent to redeem in accordance with the procedures described in the Prospectus, and we may subsequently redeem the Preferred Stock in whole, but not in part, at a redemption price equal to $10,000 per share (equivalent to $25 per depositary share), plus any declared and unpaid dividends on the shares of Preferred Stock called for redemption up to the redemption date. Dividends will cease to accrue on those shares on the redemption date, without accumulation of undeclared dividends. (see Prospectus) USE OF PROCEEDS: General Corporate Purposes (see Prospectus) DRD/QDI ELIGIBLE: Yes LISTING: NYSE Expected BOOKRUNNER: JPM JOINT LEAD MGRS: BofAML/CITUMS/UBS/WFS CO-MGRS: TBD SETTLE: T+5 The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at ‘‘ ww.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling collect You should not reply to this announcement. Any reply e-mail communications, including those you generate using the "Reply" function on your e-mail software, will be ignored or rejected. This notice does not constitute an offer to sell or a solicitation of an offer to buy securities in any jurisdiction where such offer or solicitation would be unlawful, and does not constitute an offer to sell or a solicitation of an offer to buy or an advertisement in respect of securities in any province or territory of Canada other than the province of Ontario unless the issuer has securities listed or quoted on one of the exchanges or markets referred to in the definition of "OTC Issuer" in Multilateral Instrument 51-105. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. THIS IS FOR INFORMATION ONLY, NOT AN OFFER OR SOLICITATION FOR THE PURCHASE OR SALE OF ANY FINANCIAL INSTRUMENT, NOR AN OFFICIAL EFTA_R1_00314530 EFTA01892984 CONFIRMATION OF TERMS. THE INFORMATION IS BELIEVED TO BE RELIABLE, BUT WE DO NOT WARRANT ITS COMPLETENESS OR ACCURACY. PRICES AND AVAILABILITY ARE INDICATIVE ONLY AND ARE SUBJECT TO CHANGE WITHOUT NOTICE. WE MAY HOLD A POSITION OR ACT AS A MARKET MAKER IN ANY FINANCIAL INSTRUMENT DISCUSSED HEREIN. CLIENTS SHOULD CONSULT THEIR OWN ADVISORS REGARDING ANY TAX, ACCOUNTING OR LEGAL ASPECTS OF THIS INFORMATION AND EXECUTE TRANSACTIONS THROUGH A J.P. MORGAN ENTITY IN THEIR HOME JURISDICTION UNLESS GOVERNING LAW PERMITS OTHERWISE. This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email. ******* ****** ************************** ******************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return c-mail or by c-mail to jeevacati n mail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00314531 EFTA01892985